Madopar

Levodopa/Benserazide, the active ingredients in Madopar, are an antiparkinson agent presented as an oral tablet for oral use. They act as a dopamine precursor combined with a peripheral decarboxylase inhibitor to manage Parkinson's disease and Parkinsonian syndromes in adult patients.

GNH USA supplies Madopar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets. Its distribution network ensures timely delivery and compliance with local regulatory requirements.

Madopar is used in the management of Parkinsonian disorders, targeting dopaminergic deficiency in the central nervous system. - Parkinson's disease: improves motor symptoms such as bradykinesia, rigidity and tremor. - Parkinsonian syndrome: alleviates motor dysfunction associated with secondary Parkinsonism. - Early-stage Parkinson's disease: provides symptomatic relief to delay functional decline. - Motor fluctuations in advanced Parkinson's disease: reduces OFF periods and improves ON time. - Dyskinesia management: used with other agents to balance motor complications.

Madopar may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Orthostatic hypotension: dizziness upon standing. - Dyskinesia: involuntary movements, especially at higher doses. - Insomnia: difficulty sleeping.

Serious or Rare Side Effects: - Neuroleptic malignant syndrome: life‑threatening reaction with fever and rigidity. - Severe psychiatric disturbances: hallucinations or psychosis. - Cardiac arrhythmias: irregular heart rhythm requiring medical attention.

When prescribing Madopar, clinicians should consider several precautionary measures to ensure safe use. - Renal impairment: adjust dose as benserazide is renally excreted. - Hepatic disease: monitor liver function due to levodopa metabolism. - Cardiovascular disease: use caution in patients with arrhythmias or ischemic heart disease. - Psychiatric history: observe for emergence of hallucinations or psychosis. - Pregnancy and lactation: avoid use unless benefits outweigh potential risks. - Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture.

Madopar can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis. - Antipsychotics (e.g., haloperidol): may diminish antiparkinson effect.

Moderate Interactions (Monitor Closely): - COMT inhibitors (e.g., entacapone): increase levodopa levels, may require dose adjustment. - Iron supplements: reduce levodopa absorption; separate administration by at least 2 hours. - Antihypertensives: additive effect on blood pressure, monitor for hypotension.